Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
REGN compared with BNY: revenue, margins and what each company keeps, and the suppliers and customers both name
REGN
Regeneron Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
BNY
Bank of New York Mellon Corp
Change
Mkt cap
Revenue
Revenue
vs
Compare
REGN
Regeneron Pharmaceuticals, Inc.
vs
BNY
Bank of New York Mellon Corp
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
BNY: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only REGN
26
—
Two distributor customers
unlisted
customer
BMY
Bristol-Myers Squibb
supplier
ALNY
Alnylam Pharmaceuticals
supplier
RARE
Ultragenyx Pharmaceutical
customer
22 more · REGN chain
›
Shared
0
No disclosed counterparties: BNY.
Only BNY
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
REGN, solid
BNY, dashed
REGN
Regeneron Pharmaceuticals, Inc.
Change
924.44
▲
+12.91%
· post 927.38
Mkt cap
$96.0B
Revenue
$5.1B
Q3 FY26
Revenue
$14.3B
FY25
BNY
Bank of New York Mellon Corp
Change
147.09
▼
−1.53%
· post 147.12
Closed
Oct 30 '26
Mkt cap
$99.0B
Revenue
$5.7B
Q3 FY26
Revenue
$20.1B
FY25
vs
Compare
Closed
Oct 30 '26
REGN
Regeneron Pharmaceuticals, Inc.
vs
BNY
Bank of New York Mellon Corp
924.44
▲
+12.91%
post 927.38
Price
147.09
▼
−1.53%
post 147.12
$96.0B
Mkt cap
$99.0B
Q3 FY26
$5.1B
Revenue
$5.7B
Q3 FY26
FY25
$14.3B
Revenue
$20.1B
FY25
Change
Change
REGN
924.44
▲
+12.91%
vs
BNY
147.09
▼
−1.53%
Closed
Oct 30 '26